Pharmaceuticals, Biotechnology and Life Sciences
Proceeds Will Advance Ophthalmic Clinical Trials of Lead Drug Candidate Nyxol® for Night Vision Disturbances, Glaucoma, and Reversal of Mydriasis…
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA™”) (NYSE: IQV) has been named to the Forbes 2019…
DUBLIN–(BUSINESS WIRE)–The “Ovarian Cancer Treatment Market – Forecasts from 2019 to 2024” report has been added to ResearchAndMarkets.com’s offering. The…
Conference Call and Webcast Scheduled for 1:30 p.m. PDT SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology…
Recent pre-clinical data supports development of poziotinib for osimertinib resistance, as well as atypical mutations. Three new cohorts are currently…
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#DigitalDrugDesign–Exicure, Inc. (OTCQB: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid…
– Company has launched 21 generic products so far in 2019 – BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today…
Novel, Non-Invasive Drug Delivery Platform Expands Glaukos’ Portfolio of Sustained Pharmaceutical Systems Includes Lead Candidate for Treatment of Dry Eye…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, Inc. (Nasdaq: EPZM), a late-stage biopharmaceutical company developing novel epigenetic therapies, today announced the appointment of Paolo…
WALLINGFORD, England–(BUSINESS WIRE)–Research partners from pharma, academia, and SMEs have come together to form the Reward Task Optimisation Consortium (RTOC).…